About Us
Driven by Passion. Defined by Excellence.
Established with a pure aim of striving for excellence, Ohm Pharmaceuticals Lab. Pvt. Ltd. (OPL) stands today as one of Nepal’s most trusted and progressive pharmaceutical companies. Guided by our enduring vision – “Passion to Excellence” – we are committed to improving lives through high-quality, safe, and affordable medicines. Registered on Asadh 3, 2060 B.S. and officially licensed by the Department of Drug Administration (DDA) on Poush 10, 2060 B.S., OPL commenced its commercial operations on Asadh 15, 2066 B.S. Since then, our journey has been marked by continuous growth, uncompromising quality and safety, and consistency that patients can trust.
A significant milestone in our history is being the first pharmaceutical company in Nepal to receive WHO-GMP certification for hormonal drugs, a testament to our robust manufacturing systems, strict regulatory compliance, and adherence to global quality standards. Today, OPL’s quality-driven medicines serve as the backbone of our success, reinforcing our position as a leading pharmaceutical manufacturer in Nepal and strengthening our commitment to help people live healthier, more fulfilling lives.
Being the first pharmaceutical company to receive WHO GMP for the hormonal drugs, OPL constantly endeavors to fulfill its mission “Passion to Excellence” and help people live lively. OPL offers outstanding manufacturing services complying with the systematic disciplines of WHO GMP. We carry a broad experience in the production of promising products. OPL believes in developing medicines and products that are cost-effective as well are capable of providing high quality care to improve the health of the patients. We are also focused on enhancing our services and technologies to expand the benefits of our products nationally and internationally.
History of OPL
2060 B.S.
Foundation & Registration
OPL was established with the vision of “Passion to Excellence,” laying a strong foundation for pharmaceutical manufacturing in Nepal.
2066 B.S.
Market Entry
Commercial operations commenced with the introduction of high-quality, affordable medicines to the Nepalese healthcare market.
2068 B.S.
WHO-GMP Certification
OPL achieved National WHO-GMP certification for its manufacturing facility, marking a major milestone in regulatory compliance, quality assurance, and patient safety.
2070 B.S.
WHO-GMP Certification for hormonal products
OPL achieved a major milestone by becoming the first pharmaceutical company in Nepal to receive WHO-GMP certification for hormonal drugs, setting benchmarks for quality and compliance.
2067 B.S.
Launch of Obeslim
Entry into the wellness and metabolic segment with Obeslim, which rapidly emerged as one of OPL’s most successful and trusted brands.
2080 B.S.
Establishment of Hormone-Dedicated Section
A specialized manufacturing section for hormonal products was inaugurated to enhance quality assurance, specialization, and regulatory compliance.
2081 B.S.
Establishment of Steroid-Dedicated Section
To strengthen its therapeutic portfolio, OPL established a dedicated steroid manufacturing section with stringent contamination control and GMP standards.
2081 B.S.
Launch of Endosis
OPL expanded its gynecology portfolio with Endosis, Nepal’s first brand of dienogest 2mg, reaffirming its commitment to women’s health and specialized care.
Mission
With a passion for excellence, we consistently deliver high-quality, safe, and affordable medicines while building enduring trust with healthcare professionals and patients—responsibly addressing the nation’s unmet therapeutic needs.
O
Optimize healthcare outcomes by delivering safe, effective, and high-quality medicines.
P
Pursue innovation and excellence to meet unmet therapeutic needs with integrity and care.
L
Lead with a people-centered culture that empowers our team and expands our impact nationally and internationally.
Vision
O
Outstanding services & quality medicines
P
Pioneering therapies through new molecules
L
Leadership driven by an innovative corporate culture
Core Values
1. Harmony
We foster harmony by collaborating effectively, respecting diverse perspectives, and acting responsibly toward patients, partners, society, and the environment.
2. Aspiration
We aspire to grow and continuously improve – challenging ourselves to learn, adapt, and raise standards in quality and patient care.
3. Achievement
We are driven to achieve meaningful outcomes, act with accountability – delivering safe, effective medicines that create lasting value for patients and the nation.
Quality Policy
We shall build-in current regulatory expectations of risk-based approach in our quality management system and work as an integrated team to produce safe, stable and effective medicines at affordable price for the customers. Our actions shall be based on passion for excellence, ethics and a positive culture with freedom of expression for continual improvement.
Our Objectives
- To meet the sheer expectations of Nepalese Medical Sector in designing and producing the allopathic medicines.
- To ensure value, satisfaction, quality in terms of pharmaceutical production, moreover, availability and according services to our intermediaries and valued customer.
- To deliver optimal value creation process and transactions ethically, among the associated trade organizations.
- To put an endeavor to target all possible Nepalese Pharmaceutical Market with the Modern marketing Concepts applied.
- To thrive for optimum utilization of the available resources to achieve the excellence in the pharmaceutical production and promotion.
- To carry out “Research & Development” activities to meet our “P” vision.
- To substitute the import of pharmaceuticals production thereby bridging the gap between demand and supply.
- To set a benchmark for other by covering the milestones in the overall pharmaceutical development.
